share_log

DA Davidson Maintains Neutral on Medifast, Lowers Price Target to $71

Benzinga ·  May 2, 2023 04:23

DA Davidson analyst Linda Bolton Weiser maintains Medifast (NYSE:MED) with a Neutral and lowers the price target from $94 to $71.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment